You are here: Home » PTI Stories » National » News
Business Standard

Lupin launches skin ointment in US

Press Trust of India  |  New Delhi 

Drug firm Tuesday said it has launched generic Propionate ointment used for treatment of and caused by a number of skin conditions in the US market.

The company has launched Propionate ointment USP in the strength of 0.05 per cent. It had earlier received approval for the product from the Food and Drug Administration (USFDA), said in a statement.

The company's product is the generic version of Fougera Pharmaceuticals Inc's Temovate ointment in the same strength, it added.

As per the IQVIA MAT June 2018 data, Propionate Ointment USP 0.05 per cent had annual sales of around USD 93.4 million in the US, it said.

"It is a super-high potency corticosteroid indicated for the relief of the of corticosteroid-responsive dermatoses," added.

Shares of Lupin closed at Rs 865.50 per scrip on the BSE, up 2.15 per cent from its previous close.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Tue, October 09 2018. 16:50 IST